Abstract
Recent neuroscientific evidence indicates that psychopathy is associated with abnormal function and structure in limbic and paralimbic areas. Psychopathy and substance use disorders are highly comorbid, but clinical experience suggests that psychopaths abuse drugs for different reasons than non-psychopaths, and that psychopaths do not typically experience withdrawal and craving upon becoming incarcerated. This study examined the modulatory effect of psychopathic traits on the neurobiological craving response to pictorial drug stimuli. Using functional magnetic resonance imaging (fMRI) on a sample of 137 incarcerated adult offenders with histories of substance dependence, the study found a negative association between psychopathy scores (PCL-R) and hemodynamic activity in the anterior cingulate, posterior cingulate, hippocampus, amygdala, and parts of the prefrontal cortex when viewing drug-related cues. These results suggest that psychopathic traits significantly modulate the neurobiological craving response, highlighting the importance of individual differences in treating substance abuse.
The Addiction Paradox in Psychopathy
There is a well-documented "addiction paradox" regarding psychopathy. While individuals with high psychopathic traits are statistically more likely to develop polysubstance dependence, clinical observations dating back to the 1940s suggest they rarely experience the intense physiological withdrawal or "craving" symptoms typical of other users when access to drugs is restricted, such as during incarceration. This study sought to investigate whether the neurobiological machinery of craving functions differently in this population by examining "cue-reactivity"—the neural response to drug-related imagery.
Methodology and Participant Profile
The researchers utilized a unique sample of 137 incarcerated adult offenders (44 males, 93 females) from two correctional facilities in New Mexico. All participants had a history of lifetime dependence on methamphetamine, heroin, or cocaine. Data were collected using a mobile 1.5T MRI system.
During the fMRI task, participants viewed 32 drug-related pictures (depicting cocaine, heroin, or methamphetamine use) and 32 neutral pictures. After each image, participants provided subjective ratings of their current craving level. Psychopathy was assessed using the Hare Psychopathy Checklist-Revised (PCL-R), which distinguishes between Factor 1 (interpersonal/affective) and Factor 2 (social deviance/impulsivity) traits.
Key Results: Neural Under-Reactivity to Drug Cues
The most striking finding was a consistent negative association between psychopathy scores and brain activity in the "craving circuit." As psychopathic traits increased, activity in limbic and paralimbic areas decreased significantly when viewing drug cues compared to neutral cues.
Specific findings included:
- Whole-Brain Analysis: Higher PCL-R scores correlated with reduced activity in the anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), hippocampus, amygdala, caudate, and globus pallidus.
- Factor 2 Dominance: The reduced neural response was more strongly associated with Factor 2 (impulsive/antisocial lifestyle) than Factor 1 (interpersonal traits), suggesting that behavioral instability is closely tied to these neural abnormalities.
- Brain-Behavior Dissociation: Interestingly, while neural reactivity was reduced, subjective ratings of craving did not significantly correlate with psychopathy scores. This suggests a gap between the physiological experience of craving and the cognitive report of it.
Discussion and Implications
The results support the "paralimbic hypothesis," suggesting that psychopathy involves fundamental dysfunction in regions like the ACC and amygdala, which are typically hyper-reactive during drug craving in non-psychopathic populations. The authors propose a distinction between "liking" and "wanting"; while psychopaths may enjoy the effects of drugs (positive reinforcement), they may lack the "incentive salience" or intense "wanting" (craving) that typically drives relapse.
These findings have significant implications for treatment. Standard "craving-reduction" therapies may be less effective for high-psychopathy offenders. Future interventions might find more success by targeting impulsivity and behavioral control rather than the physiological experience of craving.
Summary updated